Rapid dna sequencing is providing timely answers for infants with epilepsy. Genetic testing has helped in this effort, with some outlets highlighting individual cases and global research perspectives. The involvement of medical professionals and researchers, such as those at Boston Children's, suggests a collaborative approach to addressing rare diseases like infant epilepsy.